Cynthia W. Hu - 16 Aug 2021 Form 4 Insider Report for Decibel Therapeutics, Inc.

Reporting relationship: General Counsel
Issuer ticker: N/A
Reported as of: 16 Aug 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 18 Aug 2021, 16:55:03 UTC
Next SEC filing: 10 Jan 2022
Source filing: View source filing
Reporting owner signature: /s/ Cynthia W. Hu

Key filing fact

Cynthia W. Hu filed Form 4 for Decibel Therapeutics, Inc. on 18 Aug 2021.

Key facts

This page summarizes Cynthia W. Hu's Form 4 filing for Decibel Therapeutics, Inc..
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 18 Aug 2021, 16:55.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

DBTX transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +150,000
Change %
Price: $0.000000
Shares after: 150,000
Date: 16 Aug 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 150,000
Exercise price: $7.37
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option was granted on August 16, 2021. The shares underlying the option are scheduled to vest with respect to 25% of the shares on the first anniversary of the grant date and as to the balance of such shares in 36 equal month installments thereafter until the fourth anniversary of the grant date, subject to the reporting person's continued service.